90 (940 90)
Irbesartan Tablet
Product Images NDC 42291-941
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Irbesartan (NDC 42291-941). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
90 (941 90)
90 (942 90)
Figure1 (Fig1)
This text provides information about the dosages of Irbesartan ranging from 150 mg/day to 900 mg/day. It also mentions a placebo-subtracted reduction in trough SeSBP and SeDBP through integrated analysis, highlighting the effectiveness of Irbesartan in reducing blood pressure.*
Figure3 (Figure3)
This data appears to show the Cumulative Event Rate (%) for different groups over various months of follow-up. The groups include Irbesartan, Amlodipine, and Placebo. The event rates and comparisons between Irbesartan vs. Placebo, and Irbesartan vs. Amlodipine are provided along with corresponding relative risks and p-values. The follow-up duration ranges from 6 to 60 months.*
Structure (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
